ConductScience.org, home

Paper40713639

Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.

Salvati A and 14 others. J Transl Med, 2025. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies. Papers, record 40713639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40713639

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.
PubMed
Journal
J Transl Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
6.59, provisional
iCite
Revised in PubMed
2026-08-06
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salvati AAnnamaria
2Melone VViola
3Giordano AAlessandro
4Lamberti JJessica
5Palumbo DDomenico
6Palo LLuigi
7Rea DDilia
8Memoli DDomenico
9Simonis VVittoria
10Alexandrova EElena
11Silvestro FFrancesco
12Rizzo FFrancesca
13Weisz AAlessandro
14Tarallo RRobertahttps://orcid.org/0000-0001-9668-3632
15Nassa GGiovanni

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug RepositioningMajor topic
Artificial IntelligenceMajor topic
Epigenesis, GeneticMajor topic
NeoplasmsMajor topic
Humans
Female
Breast Neoplasms
Multiomics

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
IG-23068Fondazione AIRC per la ricerca sul cancro ETSPubMed
202282CMEAMinistero dell'Università e della RicercaPubMed
2022A7HJEMMinistero dell'Università e della RicercaPubMed

Source PubMed

Download CSV of grants

References227

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115988529Global histone modification patterns predict risk of prostate cancer recurrence.Nature2005https://conductscience.org/library/papers/15988529PubMed
221576221Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling.Nucleic Acids Res2011https://conductscience.org/library/papers/21576221PubMed
324994966Histone H3 lysine 27 acetylation is altered in colon cancer.Clin Proteomics2014https://conductscience.org/library/papers/24994966PubMed
418347167Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.Clin Cancer Res2008https://conductscience.org/library/papers/18347167PubMed
521423274Readers of histone modifications.Cell Res2011https://conductscience.org/library/papers/21423274PubMed
635427480Beyond the marks: reader-effectors as drivers of epigenetics and chromatin engineering.Trends Biochem Sci2022https://conductscience.org/library/papers/35427480PubMed
729651053Targeted in situ genome-wide profiling with high efficiency for low cell numbers.Nat Protoc2018https://conductscience.org/library/papers/29651053PubMed
828689145Allosteric regulation of epigenetic modifying enzymes.Curr Opin Chem Biol2017https://conductscience.org/library/papers/28689145PubMed
930364956HMDD v3.0: a database for experimentally supported human microRNA-disease associations.Nucleic Acids Res2019https://conductscience.org/library/papers/30364956PubMed
1034786648The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia.Adv Ther2022https://conductscience.org/library/papers/34786648PubMed
1130478442A primer on deep learning in genomics.Nat Genet2019https://conductscience.org/library/papers/30478442PubMed
1233879235Advances in epigenetic therapeutics with focus on solid tumors.Clin Epigenetics2021https://conductscience.org/library/papers/33879235PubMed
1326865995HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases.Chonnam Med J2016https://conductscience.org/library/papers/26865995PubMed
1418004079Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.Oncology2007https://conductscience.org/library/papers/18004079PubMed
1529264942MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data.Epigenomics2018https://conductscience.org/library/papers/29264942PubMed
1632079180Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/32079180PubMed
1721559012A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.Br J Cancer2011https://conductscience.org/library/papers/21559012PubMed
1821889194BET bromodomain inhibition as a therapeutic strategy to target c-Myc.Cell2011https://conductscience.org/library/papers/21889194PubMed
1938640748
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations.
ESMO Open2024https://conductscience.org/library/papers/38640748PubMed
2039138146Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39138146PubMed

See all 227 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42882485The Crosstalk Between Metabolic Reprogramming and Histone Methylation in Tumor Immunity and Immunotherapy.Cells2026https://conductscience.org/library/papers/42882485PubMed
42840418The impact of epigenetics on tumor metabolism: Friend or foe in drug response?Front Epigenet Epigenom2026https://conductscience.org/library/papers/42840418PubMed
42610144AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42610144PubMed
42405329Tumor suppressor network dysregulation in neuroblastoma: molecular mechanisms and precision therapeutic opportunities.Front Cell Dev Biol2026https://conductscience.org/library/papers/42405329PubMed
42347061From Laboratory to Patient Access: A Scoping Review of the Multi-Dimensional Challenges in Drug Repurposing.Pharmacy (Basel)2026https://conductscience.org/library/papers/42347061PubMed
42346864c-Myc-Induced Therapy Resistance in Leukemia: Mechanisms and Emerging Therapeutic Opportunities.Med Sci (Basel)2026https://conductscience.org/library/papers/42346864PubMed
42130861PTM encoding: decoding the mechanisms of exercise-induced metabolic memory through spatiotemporal modification networks.Front Sports Act Living2026https://conductscience.org/library/papers/42130861PubMed
42058150Bridging science and hope: the evolving story of gene therapy for neuromuscular diseases.Front Cell Dev Biol2026https://conductscience.org/library/papers/42058150PubMed
42052446Multimodal artificial intelligence in urologic precision oncology: from algorithm to translational medicine (a systemized narrative review).Front Oncol2026https://conductscience.org/library/papers/42052446PubMed
41971420Breast cancer pathogenesis, diagnosis and treatment: a comprehensive review.Front Oncol2026https://conductscience.org/library/papers/41971420PubMed
41618311Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin.Cell Commun Signal2026https://conductscience.org/library/papers/41618311PubMed
41523619Mapping the Landscape of Anti-Breast Cancer Drug Discovery in Saudi Arabia: A Bibliometric Analysis (2019-2023).Scientifica (Cairo)2025https://conductscience.org/library/papers/41523619PubMed
41471222From Methylomes to CRISPR Epigenetic Editing: New Paths in Antibiotic Resistance.Pathogens2025https://conductscience.org/library/papers/41471222PubMed
41439866Integrating New Approach Methodologies (NAMs) into Preclinical Regulatory Evaluation of Oncology Drugs.Biomimetics (Basel)2025https://conductscience.org/library/papers/41439866PubMed
41329030Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy.Cancer Rep (Hoboken)2025https://conductscience.org/library/papers/41329030PubMed
41311372Emerging hallmarks and the rise of complexities and heterogeneity of tumor.Biochem Biophys Rep2025https://conductscience.org/library/papers/41311372PubMed
41266662AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions.Clin Exp Med2025https://conductscience.org/library/papers/41266662PubMed
41209039Computational strategies in tumor phylogenetics: evaluating multimodal integration and methodological trade-offs across study designs.Bioinform Adv2025https://conductscience.org/library/papers/41209039PubMed
41150690Regulatory challenges and opportunities in cell-based therapies: overcoming barriers to advancement and patient care.Regen Med2025https://conductscience.org/library/papers/41150690PubMed
41057770MMP11 predicts colorectal cancer outcomes and its inhibitor RXP03 exerts anti-tumor effects via apoptosis activation.BMC Gastroenterol2025https://conductscience.org/library/papers/41057770PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40713639

GET https://conductscience.org/api/papers/v1/40713639/references?page=2